AI
Friday, February 21, 2014 11:01:13 PM
HZNP @ Stockcharts
Been a solid winner in 2014...MFI..follow the money!
Why Horizon Pharma (HZNP) Is Up Today
http://www.thestreet.com/story/12283349/1/why-horizon-pharma-hznp-is-up-today.html?puc=yahoo&cm_ven=YAHOO
NEW YORK (TheStreet) -- Horizon Pharma (HZNP_) was rising 18.82% to $10.10 in afternoon trading on Wednesday after the pharmaceutical company announced its preliminary results for the fourth quarter and fiscal year 2013.
The company expects total net revenues to be between $31.9 million and $32.4 million for the fourth quarter and between $79.5 million and $80 million for the fiscal year. The company also provided an update on the status of its osteoarthritis drug VIMOVO and announced that all required FDA transfers, including the New Drug Application (NDA) and Investigational New Drug (IND), have been completed. Furthermore, Horizon-labeled inventory "has been manufactured, shipped and sold into the wholesale and pharmacy channel," according to the company's statement.
Been a solid winner in 2014...MFI..follow the money!
Why Horizon Pharma (HZNP) Is Up Today
http://www.thestreet.com/story/12283349/1/why-horizon-pharma-hznp-is-up-today.html?puc=yahoo&cm_ven=YAHOO
NEW YORK (TheStreet) -- Horizon Pharma (HZNP_) was rising 18.82% to $10.10 in afternoon trading on Wednesday after the pharmaceutical company announced its preliminary results for the fourth quarter and fiscal year 2013.
The company expects total net revenues to be between $31.9 million and $32.4 million for the fourth quarter and between $79.5 million and $80 million for the fiscal year. The company also provided an update on the status of its osteoarthritis drug VIMOVO and announced that all required FDA transfers, including the New Drug Application (NDA) and Investigational New Drug (IND), have been completed. Furthermore, Horizon-labeled inventory "has been manufactured, shipped and sold into the wholesale and pharmacy channel," according to the company's statement.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
